Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
8 drugs in development
By Therapeutic Area
top 5
R&D Momentum
92/100
Pipeline Velocity
74/100
Trial Completion Rate
85/100
Pipeline Concentration
24/100
Pipeline Freshness
80/100
Strategic Signals
Activity
Last 14 days
OHANA Project: Optimizing Health Care Through Alignment and Care Across Cultures
Selective Axillary Dissection After Neoadjuvant Chemotherapy in Patients With Lymphnode-positive Breast Cancer
Efficacy and Safety of Fecal Microbiota Transplantation by Oral Capsules in Patients With Liver
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
Clinical Outcome of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients With Severe Left Ventricular Disfunction: the CROWN Study.
Setting Up ctDNA Analysis on Archived Plasma Samples to Personalize Adjuvant Treatment in Early-Stage Ovarian Cancer
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
Impact of Preoperative Oncogeriatric Assessment in Elderly Patients Undergoing Surgery for Hepatectomy
Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study
Contrasting Chronic Inflammation and Neurodegeneration Using the Human Amniotic Mesenchymal Cell Secretome as an Innovative Therapeutic Strategy
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)